Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Healed Culprit Plaques in Patients With Acute Coronary SyndromesFracassi F, Crea F, Jang IK et al. -
Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary SyndromesKS Rathod, S Koganti, AK Jain et al.
-
Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic ShockSS Dhruva, JS Ross, BJ Mortazavi et al.
-
Impact of Percutaneous Coronary Intervention for Chronic Total Occlusion in Non-Infarct-Related Arteries in Patients With Acute Myocardial Infarction (from the COREA-AMI Registry)Choi IJ, Koh YS, Kim PJ et al.
-
Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart AssociationHayes SN, American Heart Association Council on Peripheral Vascular Disease; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Genomic and Precision Medicine; and Stroke Council.
-
Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE TrialHenriques JP, Hoebers LP, EXPLORE Trial Investigators.
-
Culprit lesion location and outcome in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trialFuernau G, Fengler K, Thiele H et al.
-
Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary SyndromeChen JY, He PC, Tan N et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
